Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 바이오시밀러

Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO) (HT073026)

Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
가격(USD):
사양:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HT073026
설명
Vanucizumab (HT073026) is a research-grade recombinant antibody targeting Vascular endothelial growth factor A. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
종 반응성Human
응용 분야ELISA, Bioactivity: FACS, Functional assay, Research in vivo
숙주 종Human
클론성Monoclonal
이소타입human IgG1 - kappa - lambda with half-IG VL-CH1/VH-CK crossover
발현 시스템 Mammalian cells
테스트된 응용 분야 FCM
타겟 Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A, ANG-2, ANGPT2, Angiopoietin-2
내독소 수준 < 10 EU/mg
순도 >95% purity as determined by SDS-PAGE.
정제 Protein A/G purified from cell culture supernatant.
등록번호 P15692 & O15123
형태 Liquid
저장 완충액 0.01M PBS pH 7.4

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
대체 이름Bispecific, RG-7221, RG7221, RO5520985, 1448221-05-3
배경Zifibancimig is an anti-VEGFA/ANGPT2 IgG1κ monoclonal antibody.
참고사항 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (HyHEL-10) (HV080407)
Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
이미지
  • Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)

    Bioactivity

    Detects Human VEGFA in indirect ELISAs.

  • Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Vanucizumab.

  • Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)

    Bioactivity

    Detects Human ANGPT2 in indirect ELISAs.

  • Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)

    Flow CytoMetry

    Flow-cytometry using FITC anti-human VEGFA&ANGPT2 antibody. U87 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human VEGFA&ANGPT2 monoclonal antibody (Catalog: HT073026, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록